Javascript must be enabled to continue!
Supplementary Figures from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
View through CrossRef
<p>Supplementary Figures 1-9. Supplementary Fig. S1 Wnt/β-catenin-dependent reporter activity in ECC10 cells. Supplementary Fig. S2 Effect of E7386 on the interaction between β-catenin and p300 in ECC10 cells. Supplementary Fig. S3 Comparison of IC50 values among β-catenin/CBP inhibitors, as determined by HEK-293 TCF/LEF reporter assay. Supplementary Fig. S4 Upstream regulators of gene expression changes in whisker follicle tissues of ApcMin/+ mice treated with E7386. Supplementary Fig. S5 Inhibitory activity of E7386 against cell growth in ECC10 cells. Supplementary Fig. S6 Antitumor activity of E7386 and ICG-001 in a human ECC10 gastric tumor xenograft model. Supplementary Fig. S7 Gating strategy for the flow cytometry analysis of myeloid and T-cell populations. Supplementary Fig. S8 Flow cytometry analysis of the effect of E7386 on immune cell populations in the MMTV-Wnt1 model. Supplementary Fig. S9 Effect of PRI-724 on spontaneous intestinal polyp formation in ApcMin/+ mice.</p>
American Association for Cancer Research (AACR)
Kazuhiko Yamada
Yusaku Hori
Satoshi Inoue
Yuji Yamamoto
Kentaro Iso
Hiroshi Kamiyama
Atsumi Yamaguchi
Takayuki Kimura
Mai Uesugi
Junichi Ito
Masahiro Matsuki
Kazutaka Nakamoto
Hitoshi Harada
Naoki Yoneda
Atsushi Takemura
Ikuo Kushida
Naomi Wakayama
Kenji Kubara
Yu Kato
Taro Semba
Akira Yokoi
Masayuki Matsukura
Takenao Odagami
Masao Iwata
Akihiko Tsuruoka
Toshimitsu Uenaka
Junji Matsui
Tomohiro Matsushima
Kenichi Nomoto
Hiroyuki Kouji
Takashi Owa
Yasuhiro Funahashi
Yoichi Ozawa
Title: Supplementary Figures from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
Description:
<p>Supplementary Figures 1-9.
Supplementary Fig.
S1 Wnt/β-catenin-dependent reporter activity in ECC10 cells.
Supplementary Fig.
S2 Effect of E7386 on the interaction between β-catenin and p300 in ECC10 cells.
Supplementary Fig.
S3 Comparison of IC50 values among β-catenin/CBP inhibitors, as determined by HEK-293 TCF/LEF reporter assay.
Supplementary Fig.
S4 Upstream regulators of gene expression changes in whisker follicle tissues of ApcMin/+ mice treated with E7386.
Supplementary Fig.
S5 Inhibitory activity of E7386 against cell growth in ECC10 cells.
Supplementary Fig.
S6 Antitumor activity of E7386 and ICG-001 in a human ECC10 gastric tumor xenograft model.
Supplementary Fig.
S7 Gating strategy for the flow cytometry analysis of myeloid and T-cell populations.
Supplementary Fig.
S8 Flow cytometry analysis of the effect of E7386 on immune cell populations in the MMTV-Wnt1 model.
Supplementary Fig.
S9 Effect of PRI-724 on spontaneous intestinal polyp formation in ApcMin/+ mice.
</p>.
Related Results
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract
Carcinogenesis is often accelerated by the aberrant activation of components molecules of Wnt signaling pathway, especially, APC and beta-catenin are freque...
Data from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
Data from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
<div>Abstract<p>The Wnt/β-catenin signaling pathway plays crucial roles in embryonic development and the development of multiple types of cancer, and its aberrant activ...
Abstract 5172: E7386, an orally active CBP/beta-catenin modulator, induces T cells infiltration into tumor and enhances antitumor activity of anti-PD-1 mAb in Wnt1 tumor syngeneic mice model
Abstract 5172: E7386, an orally active CBP/beta-catenin modulator, induces T cells infiltration into tumor and enhances antitumor activity of anti-PD-1 mAb in Wnt1 tumor syngeneic mice model
Abstract
Recently, immunotherapeutic approaches have come to forefront in melanoma, non-small cell lung cancer, bladder cancer, and so on. However, sufficient benefi...
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Abstract
Abstract 1851
Background:
The proteasome inhibitor Bortezomib (Bz) shows significant activity in Multipl...
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract
Background: Prostate cancer (PCa) is the leading cancer among men in the world. Androgen deprivation therapy is a common treatment to cease prostate growth....
WNT Signaling Pathway and Stem Cell Signaling Network
WNT Signaling Pathway and Stem Cell Signaling Network
Abstract
WNT signals are transduced to the canonical pathway for cell fate determination, and to the noncanonical pathway for control of cell movement and tissue pol...
Abstract 1713: Macrophage-induced bystander effect activates Wnt/β-catenin signaling and induces cellular dedifferentiation
Abstract 1713: Macrophage-induced bystander effect activates Wnt/β-catenin signaling and induces cellular dedifferentiation
Abstract
Cancer stem cells (CSCs) in colorectal cancer (CRC) help maintain tumor heterogeneity, promote tumor growth, invasion, and metastasis, and produce resistanc...
Wnt/β-catenin/HNF4α feedback loop facilitates colorectal tumorigenesis and malignancy
Wnt/β-catenin/HNF4α feedback loop facilitates colorectal tumorigenesis and malignancy
Abstract
Background: The Wnt/β-catenin signaling pathway is a central regulator of colorectal cancer (CRC) development, yet its downstream targets and mechanistic contribut...

